SCHEMBL27501722

SCHEMBL27501722

COC(=O)c1ccc(Oc2ccccc2I)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.53
▸ CA2 P00918 2/20 0.53
▸ TSHR P16473 1/20 0.52
▸ MAPT P10636 6/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ NPC1 O15118 1/20 0.48
▸ LPAR1 Q92633 1/20 0.47
▸ LPAR5 Q9H1C0 1/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ CA12 O43570 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11411879 0.88 CA1 (0.62) CA1CA2TSHRMAPTRAB9A
SCHEMBL9242685 0.85 RAB9A (0.65) CA1CA2TSHRMAPTRAB9A
SCHEMBL3842303 0.83 SRD5A2 (0.55) MAPTL3MBTL1LMNAALDH1A1GAA
SCHEMBL8782253 0.82 SLC6A3 (0.61) CA1CA2TSHRMAPTRAB9A
SCHEMBL1191950 0.82 TDP1 (0.68) CA1CA2TSHRMAPTRAB9A
SCHEMBL27449133 0.81 MAPT (0.56) CA1CA2TSHRMAPTRAB9A
SCHEMBL2457384 0.81 CA1 (0.53) CA1CA2TSHRMAPTRAB9A
SCHEMBL1339129 0.81 USP2 (0.57) CA1CA2TSHRMAPTRAB9A
SCHEMBL28276502 0.81 PARP10 (0.67) CA1CA2TSHRMAPTRAB9A
SCHEMBL28032723 0.80 SRD5A2 (0.56) MAPTL3MBTL1LMNAALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1154486-C Method of treating malignant tumours with thyroxine analogues having no significant hormonal activity �¿���Ĭ�ɷ����޹�˾ 2004-06-23 — — CN disclosed
CN-1226826-A Method for treating malignant tumor with thyroxine analogue without obvious hormone activity OCTAMER INC (US) 1999-08-25 — — CN disclosed
Send feedback